D.A. Davidson & Co. Regeneron Pharmaceuticals, Inc. Transaction History

D.A. Davidson & Co.

$11.2 Billion
Q2 2024

A detailed history of D.A. Davidson & Co. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, D.A. Davidson & Co. holds 781 shares of REGN stock, worth $821,018. This represents 0.01% of its overall portfolio holdings.

Number of Shares

781

Previous 709 10.16%

Holding current value

$821,018

Previous $682,000 20.23%

% of portfolio

0.01%

Previous 0.01%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 31, 2024	BUY	$883.2 - $1071.19 $63,590 - $77,125	72 Added 10.16%	781 $820,000
Q4 2023 Feb 09, 2024	BUY	$775.18 - $881.7 $79,843 - $90,815	103 Added 17.0%	709 $622,000
Q3 2023 Nov 08, 2023	SELL	$692.45 - $844.37 $208,427 - $254,155	-301 Reduced 33.19%	606 $498,000
Q2 2023 Aug 10, 2023	SELL	$700.03 - $830.35 $81,203 - $96,320	-116 Reduced 11.34%	907 $651,000
Q1 2023 Apr 25, 2023	BUY	$680.49 - $826.97 $298,735 - $363,039	439 Added 75.17%	1,023 $840,000
Q4 2022 Feb 03, 2023	SELL	$705.89 - $766.39 $9,882 - $10,729	-14 Reduced 2.34%	584 $421,000
Q3 2022 Nov 07, 2022	BUY	$573.97 - $724.32 $32,716 - $41,286	57 Added 10.54%	598 $412,000
Q2 2022 Jul 28, 2022	SELL	$548.35 - $738.84 $8,225 - $11,082	-15 Reduced 2.7%	541 $320,000
Q1 2022 May 12, 2022	BUY	$595.12 - $698.43 $34,516 - $40,508	58 Added 11.65%	556 $388,000
Q4 2021 Jan 31, 2022	BUY	$543.48 - $670.97 $8,152 - $10,064	15 Added 3.11%	498 $314,000
Q3 2021 Nov 15, 2021	SELL	$574.03 - $680.96 $11,480 - $13,619	-20 Reduced 3.98%	483 $292,000
Q2 2021 Aug 10, 2021	BUY	$472.8 - $558.54 $19,857 - $23,458	42 Added 9.11%	503 $281,000
Q1 2021 May 07, 2021	BUY	$446.73 - $548.2 $205,942 - $252,720	461 New	461 $218,000
Q3 2017 Nov 08, 2017	SELL	$431.38 - $504.0 $45,294 - $52,920	-105 Closed	0 $0
Q2 2017 Aug 11, 2017	BUY	N/A	105	105 $0

Others Institutions Holding REGN

# of Institutions

1,463

Shares Held

84.5M

Call Options Held

907K

Put Options Held

1.3M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $113B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D.A. Davidson & Co., based on Form 13F filings with the SEC.

News

Stay updated on D.A. Davidson & Co. with notifications on news.

Account